DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Access & Reimbursement

Identify the major barriers and key stakeholders to drive successful market access.

  • Understand how payer policies impact treatment decisions and affect market access to inform your strategic planning
  • Identify opportunities for your brand to capture patient share through market access in a given country or region
  • Maximize opportunities for emerging therapies by learning how predecessor brands gained favorable reimbursement – or why they stumbled

A global portfolio of brand-specific market access insights built on primary physician and payer research.

 

Develop strategies that help you overcome potential barriers to access and help your brands thrive, utilizing:

  • Surveys from physician specialists and MCO pharmacy and medical directors
  • Broad regional coverage, including disease-level analysis dedicated to the US, EU5, and select emerging markets
  • Brand-specific insights on the major hurdles driving successes or stumbles for drugs on the market
  • Analysis of the clinical benefits physicians and payers are looking for in emerging therapies and the kind of savings through direct and indirect costs payers are seeking

Learn More